DRL Launches Authorized Generic Version of Imitrex(R)* Tablets- Sumatriptan succinate

Dr. Reddy's Laboratories announced that it has launched the authorized generic version of GlaxoSmithKline's Imitrex(R) (sumatriptan succinate) tablets 25mg, 50mg, and 100mg in the United States. Dr. Reddy's is the first company to launch an authorized generic version of Imitrex(R) tablets in the US market.  In October 2006, the Company announced that it had settled patent litigation with GlaxoSmithKline relating to sumatriptan succinate tablets, the generic version of GlaxoSmithKline Imitrex(R) tablets.